Thomas Kahan
0000-0001-9909-4956
Danderyd University Hospital Corp
155 papers found
Refreshing results…
Cardiovascular risk factors are not treated to target in hypertensive patients in primary care
Ivabradine improves exercise capacity in patients with stable angina receiving beta-blockers independent of baseline HR: a subgroup analysis of the ASSOCIATE study
Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment
The Effects of Antihypertensive Treatment on the Doppler-Derived Myocardial Performance Index in Patients with Hypertensive Left Ventricular Hypertrophy: Results from the Swedish Irbesartan in Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)
Treatment of Mild to Moderate Hypertension by Gender Perspective: A Systematic Review
Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo
Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction
The Economic Consequences of Non-Adherence to Lipid-Lowering Therapy: Results From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone Results from ASCOT
Beta blockers reduce left ventricular mass less than other antihypertensive drugs: a systematic review and meta analysis
Confirmed association between neonatal phototherapy and the risk of childhood asthma
[Lower and lower cholesterol targets increase adverse effects]
[SBU should investigate what is an evidence-based and cost-effective use of statins]
Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia:
The Relationship Between the Plasma Concentration of Irbesartan and the Antihypertensive Response Is Disclosed by an Angiotensin II Type 1 Receptor Polymorphism: Results From the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial
Sex Differences in Systolic Heart Failure in the Elderly: The Prognostic Importance of Left Ventricular Mass in Women
Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris
Anti-anginal and anti-ischaemic effects of the If current inhibitor ivabradine in patients with stable angina pectoris receiving standard doses of beta-blockers. A 4-month randomised, double-blind, multicenter trial
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen
Left ventricular long-axis dysfunction in hypertensive patients - Reply
Missing publications? Search for publications with a matching author name.